Last reviewed · How we verify
Neurosteroids in PTSD - Biomarkers to Therapeutics
The purpose of this research is to determine if a study medication called Dehydroepiandrosterone (DHEA) helps to reduce PTSD symptoms in OEF/OIF/OND Veterans. In addition to finding out if DHEA is effective for treating PTSD symptoms, this research seeks to determine if DHEA is effective in treating other symptoms, such as depression and anxiety. Depression and anxiety are symptoms that are frequently present in Veterans who are experiencing PTSD. Another purpose of this research is to takes pictures of the brain using magnetic resonance imaging (MRI) and blood levels of various small molecules including neurosteroids and also proteins, which may be affected by the study drug and/or related to symptoms in Veterans with PTSD. This study seeks to determine if DHEA is changed to other compounds after it is taken by mouth and the safety and effectiveness of DHEA in Veterans with PTSD. This is an "add-on" study and Veterans enrolled in the study will continue to take all of their current medications without any changes (also called "usual care"), and DHEA or a sugar pill (also called a "placebo") will then be added to their current medication regimen.
Details
| Lead sponsor | VA Office of Research and Development |
|---|---|
| Phase | PHASE2 |
| Status | TERMINATED |
| Enrolment | 5 |
| Start date | Mon Jul 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Posttraumatic Stress Disorder
Interventions
- DHEA
Countries
United States